|
|
Volumn 335, Issue 7613, 2007, Pages 223-
|
|
FDA committees say keep rosiglitazone available but increase warnings.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ANTIDIABETIC AGENT;
ROSIGLITAZONE;
ARTICLE;
DRUG APPROVAL;
DRUG LABELING;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
UNITED STATES;
DRUG APPROVAL;
DRUG LABELING;
HUMANS;
HYPOGLYCEMIC AGENTS;
THIAZOLIDINEDIONES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 34547750430
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.39294.417442.DB Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
